Univercells is a technology company delivering novel biomanufacturing platforms to make biologicals available and affordable to all.

Univercells provides customisable solutions for viral production (human and veterinary vaccines, gene therapy vectors, oncolytic viruses), biosimilar monoclonal antibodies and enzyme replacement therapies.

The technology aims to significantly reduce the infrastructure footprint to offer cost-effective production of high-quality biologicals for small to medium size markets.

For more information: http://www.univercells.com